Ovid Therapeutics Inc.
OVID
|
|
| |
|
| Trading Volume | 1,513 |
|
|
4.04 - 0.70 |
| Market Cap Full | $ 84.1M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.4% | -5% | 38.7% | -2.2% |
| Q2 | - | -76.6% | 27.1% | -31.5% |
| Q3 | - | 14.4% | 17.1% | -14.4% |
| Q4 | - | -20.4% | -9.6% | 1.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 20.2 | -12.1 | -10 | 5.6 | -5.1 | -76.4 | 43.7 | 14.4 | - | - | - | - |
| 2023 | |||||||||||
| 34.4 | -1.2 | 4.5 | 38.8 | -1.1 | -7.3 | 9.5 | -6.3 | 14.1 | -7.6 | -16.2 | 8.2 |
| 2022 | |||||||||||
| -14 | 22.8 | -7.4 | -11.5 | -39.2 | 27.2 | -4.7 | -2 | -8.5 | -11.4 | 8.6 | 5.1 |
| 2021 | |||||||||||
| 21.7 | 5 | 36.3 | -8.7 | 13.1 | -5.8 | -4.6 | -5.4 | -4.8 | 1.2 | -4.2 | -1.5 |
| 2020 | |||||||||||
| -21.3 | -10.9 | -2.6 | 22.2 | 47 | 37.8 | -12.5 | -11 | - | -11 | 33.9 | -66.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | 0 | 2.5 | -0.4 |
| Q2 | -0.2 | 0 | -0.2 | -0.4 |
| Q3 | -0.2 | 0 | 0 | -0.3 |
| Q4 | 0 | -0.2 | 1.8 | -0.3 |
| A | -0.53 | -0.8 | 1.8 | -1.4 |